Side effects
SINGULAIR is a leukotriene receptor antagonist indicated for: • Prophylaxis and chronic treatment of asthma in patients 12 months of age and older (1
1 Asthma
Montelukast is a leukotriene receptor antagonist used as part of an asthma therapy regimen, to prevent exercise induced bronchoconstriction, and to treat seasonal allergic rhinitis
3
Generic name: montelukast sodium
It’s approved by the Food and Drug Administration (FDA) to: treat asthma
PI & CMI Trade Names and Active Ingredients containing montelukast
The Government requested the latest safety review following reports in the media of serious
Print Save
Singulair is the brand name used to market and sell an FDA-approved drug called montelukast
It inhibits bronchoconstriction, which is the narrowing of the airways
See full prescribing information for MONTELUKAST SODIUM ORAL GRANULES
Below is a text only representation of the Patient Information Leaflet (ePIL)
Oral leukotriene receptor antagonists, Prescribing information, Allergic rhinitis, CKS Oral montelukast is licensed for the symptomatic relief of seasonal allergic rhinitis in people with asthma
When montelukast is used to prevent breathing difficulties during exercise, it should be taken at least 2 hours before El montelukast se usa para prevenir sibilancias, dificultad para respirar, opresión en el pecho y tos causada por asma en adultos y niños mayores de 12 años
The solubility of montelukast in this vehicle is 5
More Montelukast tabletas, tabletas masticables y granulado se pueden tomar con o sin alimentos
Singulair (montelukast) [prescribing information]
MONTELUKAST montelukast 5 mg chewable tablet, 28 (PI, CMI) 1: 28: 5: $18
Take your MONTELUKAST SANDOZ at bedtime each day if you have both asthma and seasonal allergic rhinitis
2 Incompatibilities
The following doses of Singulair are recommended: For adults and adolescents 15 years of age and older: one 10-mg tablet
Adjust dose according to prescribing information if needed
3 The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs
Pregnancy
Therefore the treatment with montelukast should be discontinued if neuropsychiatric symptoms occur during treatment
Asthma is a common disease characterized by reversible airflow obstruction and airway hyperresponsiveness (1-3)
or after the 2008 FDA communication and prescribing information changes that first publicized the concern
4 Preparation Prepare the solution for infusion using aseptic technique as follows: Calculate the dose (mg) of required SARCLISAbased on actual patient weight (measured prior to each cycle to have the administered dose adjusted accordingly) [see Dosage and Administration (2